Micro RNA expressions of chronic hepatitis related hepatocellular carcinoma
慢性肝炎相关性肝细胞癌中微小RNA的表达
基本信息
- 批准号:24790686
- 负责人:
- 金额:$ 2.83万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Young Scientists (B)
- 财政年份:2012
- 资助国家:日本
- 起止时间:2012-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DNA damage response genes in non-tumor lesions were associated with AP1 signaling which mediates the expression of many genes in CH-B-related HCC. In contrast, signal transducers and activators of transcription 1 and phosphatase and tensin homolog in non-tumor lesions were associated with early growth response protein 1 signaling that potentially promotes angiogenesis, fibrogenesis, and tumorigenesis in CH-C-related HCC. MicroRNAs were up- or down-regulated in cancerous tissue. These expression changes were confirmed as previously.Gene expression profiling of HCC and non-tumor lesions revealed the predisposing changes of gene expression in HCC. This approach has potential for the early diagnosis and possible prevention of HCC.
非肿瘤病变中的DNA损伤应答基因与AP1信号相关,AP1信号介导ch - b相关性HCC中许多基因的表达。相反,非肿瘤病变中转录1、磷酸酶和紧张素同源物的信号转导和激活因子与早期生长反应蛋白1信号相关,该信号可能促进ch - c相关HCC的血管生成、纤维生成和肿瘤发生。microrna在癌组织中被上调或下调。这些表达变化与之前一样得到证实。HCC和非肿瘤病变的基因表达谱揭示了HCC中基因表达的易感性变化。这种方法具有早期诊断和预防HCC的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling
- DOI:10.1016/j.ygeno.2013.02.007
- 发表时间:2013-04-01
- 期刊:
- 影响因子:4.4
- 作者:Ueda, Teruyuki;Honda, Masao;Kaneko, Shuichi
- 通讯作者:Kaneko, Shuichi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UEDA TERUYUKI其他文献
UEDA TERUYUKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Atypical Chemokine Receptors orchestrate changes in vascular patterning during fibrotic liver disease via Endothelial-to-Mesenchymal Transition.
非典型趋化因子受体通过内皮-间质转化协调纤维化肝病期间血管模式的变化。
- 批准号:
MR/Y013751/1 - 财政年份:2024
- 资助金额:
$ 2.83万 - 项目类别:
Research Grant
Investigation of Endocrine-Disrupting Chemicals as Contributors to Progression of Metabolic Dysfunction Associated Steatotic Liver Disease (EDC-MASLD)
内分泌干扰化学物质对代谢功能障碍相关脂肪性肝病 (EDC-MASLD) 进展的影响的调查
- 批准号:
10092670 - 财政年份:2024
- 资助金额:
$ 2.83万 - 项目类别:
EU-Funded
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 2.83万 - 项目类别:
EU-Funded
Multi-modal non-invasive biomarker screening for high-risk undiagnosed liver disease
针对高危未确诊肝病的多模式非侵入性生物标志物筛查
- 批准号:
10073169 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Collaborative R&D
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Multicellular Organotypic Mouse Model of Alcoholic Liver Disease
酒精性肝病的多细胞器官型小鼠模型
- 批准号:
10667672 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
- 批准号:
10667861 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
- 批准号:
10646759 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Cannabidiol as a treatment for alcoholic liver disease
大麻二酚治疗酒精性肝病
- 批准号:
10753729 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Role of Interferon-Gamma / Interleukin-12 Axis in Metabolic Liver Disease
干扰素-γ/白介素-12 轴在代谢性肝病中的作用
- 批准号:
10735419 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别: